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GZm~TICS,

cys'rro FIBROSIS-ITS

THE HETEROZYGOUS STATE AIm ITS DETECTION

In 1912, Garrod and rrurtley described two children born to first
cousins parents, who, in retrospect, probably suffered from cystic
fibrosis.

This description also suggested recessive inheritance of an

'inborn error of

metabolis~1

in the pancreas.

Oystic fibrosis is described

as a generalized disease of exocrine glands, having its onset in the newborn period, infancy or early childhood.
by the follo\.ring:
2.

1.

It manifests itself clinically

Loss or diminution of pancreatic exocrine secretions.

By increased susceptibility to upper respiratory infections, and

pneumonia resulting in the pathologic changes of bronchietasis, atelectaslS and emphysema.

,-

,.

Elevation of sodium and chloride concentration

in sweat gland secretions. l
Meconi,~

ileus, a type of intestinal obstruction, was formerly

attributed to a complete absence of pancreatic enzymes, however, more
recently it has been demonstrated that the inspissation of meconium is
primarily due to abnormal intestinal mucoid secretions rather than panileus is present in 15% of all newborns who will
.,.,
be affected with cystic fibrosis.'::' It is the earliest and most severe

creatic achlia.

Meconiu~

manifestation of ti1is disease in the newborn infant.

The ai':f'ected infant

vii thout meconium ileus who appears normal at birth, f'ails to thrive satis-

factorily even though he may have an increased apoetite.

This deficiency

of pancreatic digestion results in bulky, unformed, foul smelling stools
in both infants with or 1.>1i thout meconium ileus.
The respiratory manifestations present initially as a severe nonproductive cough, which later becomes spasmociic and productive.
dysfvnction

of~the

The

mucus-producing glands of the respiratory tree results

in the formation of thick tenacious mucus within the trachea and bronchi.

2

This abnormal secretion hinders normal ciliary movement in the bronchi,
plugs the smaller bronchioles and encourages bacterial invasion of the
lungs)
The analysis of sweat for its sodium or chloride content has become
the most reliable laboratory method for confirming the diagnosis of cystic
fibrosis.

The level of sodium chloride in the sweat of a cystic fibrotic

patient is consistently fOD,r to i'ive times higher than in normal controls
in the pediatric age group.

No other disease, except adrenal insuffi-

ciency, can cause such a marked elevation of' salt in the sweat.

Use

of this sweat assay for studying various groups of adults has revealed
that a moderate percentage of heterozygote carriers of the cystic
fibrosis gene (parents 01' cystic f'ibrotic patients) also manifest a
slight moderate elevation of sweat electrolyte.

Such studies have also

suggested that certain adults vii th chronic bronchial disease, peptic ulcer
or even diabetes mellitus, may have mild forms of cystic fibrosis.

These

cases of' cystic fibrosis could possibly be detected by finding; an elevation in sweat electrolyte, but this concept has not been universally
accepted.

Interpretation of' electrolytes in the carrier, have been

clouded by an apparent increase in svfeat electroljrte level with age. it
So, the final diagnosis of cystic f'ibrosis is usually based on
the clinical signs noted in preVious paragraphs and laborator;t f'indings
of the a.1eat sodium. and chloride excretion, absent trypsin activity in
pancreatic secretions from duodenal fluid obtained by intubation or

tJ~

ice1 pancreatic changes at autopsy.
Although cystic fibrosis is almost undoubtedly a disorder of exocrine gland function, the moleculer basis for the disease is not known.
But in the great majority of' those recessive condi tiona in 'i."lhich the

biochemical defect has been elucidated this has proven to be a reduction
in the activity of' a specific enzyme.
the mutation is

I'm

In most instances the effect of

amino acid substitution in the enzyme.

Such changes

can result in a complete loss of enzyme activity, as \':fell as reduced or
altered activity.

In other recessive disorders, it appears that there

is a complete loss of any protein production as a result of the gene
mutation.
are:

The possibilities for the enzymatic defect in cystic fibrosis

a base change which results in a nonsense code; a mutation in an

operator or regu.lator gene, or even a small chromosome deletion.

Mutations

,;,hich are thought to produce a change in a structural protein, such as
collagen, are usually dominant.

It is therefore, perhaps more likely

the defect in cystic fibrosis will be found to be an enzymatic defect,
rather than a primary defect in the peptide part of a glyco-protein. 2
The familial nature of cystic fibrosis was first described in 1946. 5
A few years later it was generally concluded that the inheritance
pattern could be best explained on the basis of an autosomal recessive
gene.

Although some groups have attempted to establish a possible link-

age betT.-leen cystic fibrosis, wi til such remote associations as blood groups
and many other lin.lcages, there is now almost total agreement with the
single alltosomal gene theory.
Cystic fibrosis results from the presence of' two pathologic autosomal recessive genes in an indiVidual.

In order to produce a recessive

homozygote eacc, normal parent must cS.rry a pathologic cystic fibrotic gene.
Each parent must also have a normal gene at the cystic fibrosis locus.
other individuals who do not hs.ve the pathologic gene illOuld possess two
dominant normal alleles at the cystic fibrosis locus.
Three types of individuals with respect to the cystic :fibrosis gene

4
are thus present in the population, normal with both dominant alleles;
carrier with one normal allele and one cystic fibrosis gene; and those
afTected with t'l'IO pathologic cystic £,i 1:>rosis genes.

Presently carriers

can be detected only through the production of aff'ected children.

Almost

all af'fected children are produced by carrier pe,rents, since affected
persens (homozygotes) with cystic fibrosis rarely live to reproduce.
Carrier parents can produce three types of children:

norr:lal 1;'i'ho

have received only normal cystic fibrosis alleles, carrier or heterozygote \'11ho have received a normal allele from one parent and a pathologic
cystic fibrosis from the other parent; and a:t"'fected individuals who he,ve
received a pathologic cystic fibrosis gene from each parent.

Oarrier

parents are capable of producing these three type::;, of' offspring in the
ratio of' 1:2:1.

Thus, each child produced by such parents has one chance

in four of being either completely normal or of being affected, and one
chance in twe of being a carrier.

These chance phenomena do not change

from one pregnancy to the next, no matter what genotype the previous offspring have been, the next child has the same genetic potentialities as
all of the siblings.
Because of the rarity of carriers in the general population, it is
unusual that t,yO carriers will marry and produce affected children.
Oarriers are much more likely to occur in kindreds of' affected cases than
in the general population.

Because of the familial aggregation of the

carrier state, there is a high incidence of' consanguinity in the recessive
disease, that is, a carrier is much znore likely to marry another carrier
if the person were related, t~lan if he were not.l

Overall prevalence of the condition is not informative because of
..~.

great mortality in infancy and early childhood.

This mortality in part,

is based on the assl.:mption that of those presenting with meconium ileus

5
only about one case in three has survived until age five.

Ranges of

rlOspital reports, often with referrals, is about 1 in 600, this is
probably an unduly high estimate.

The best range worldHide seems to be

between 1 in 1,000 and 1 in 10,000, as determined by various researches.
Confirmed by most studies the incidence in the United States is closer
to 1 in 2,500.

The incidence of 1 in 2,500 implies a gene frequency

of about 1 in 50 in these popu1ations,since cousin marriage rate is
low, and a heterozygote frequency of about 1 in 25.

This disease is

rare both in Negro and Mongolian populations.
If one accepts the figure of 1 in 2,500 and a mortality of two
out of taree by the age of:fti:e, this means the.t this single condi tioD
is responsible for between one and two percent of all deaths under age
of five.

The incidence of the condition in children of surviving pa-

tients will give a direct estimate of gene frequency.7,11,12
If' the incidence of cystic fibrosis is essentially determined by

the mutation rate and hitherto there was a tIigg,mortality in childhood,
the mutation rate must be of the order of 1 in 2,500.

This is (iuite

exceptionally high for a gene mutation rate and so heterozygote advantage is suggested.

The selective advantage in the case of cystic fibro-

sis needs to be relatively small, an increase in fitness of only about
2% of heterozygotes over individuals homozygous for the normal gene.
Such a heterozygote advantage will only operate in high incidence areas,
and so a clue may ,.'ell come, as it did with sickle cell anemia and
malaria from geographical surveys of the incidence of the disease.
It is, of course, possible that the heterozygote advantage no
longer exists.

Where malaria has been eliminated there is probably

no longer any extra fitness of' heterozygotes for the sickle cell gene

6
but the high frequency \<{ilLremain in ¥.est Africa for centuries to
come.
Many attempts to demonstrate a heterozygote advantage in cystic
fibrosis have been made, but no definite conclusions concerning the
resul ts have been reached.

Using the }remise that there is an advant-

age to the carrier which would result in increased fertility, has been
examined, in light of knowledge accumulating in the literature regarding
changes in mucus and electrolyte secretions in the reproductive tract
during the normal ovulatory cycle.

Attention has been given to detect-

ing any differences that may exist between carrier cases and normal
individuals regarding these secretions, in the hope that this might
contribute kno>vledge to the underlying defect in cystic fibrosis.
Evidence of heterozygote advantage, secondary to increased
fertility, was sought by studying the size of families of grandparents
of' patients wi tn cystic fibrosis.

Despite the great care taken in .:,'

matching three different control couples with each grandparental pair,
considerable variation existed between the three series of controls.
In only one of the control groups does the i'a'TIily size differ signii'icantb from that of the fibrocystic family and even in this instance a possible explanation is suggested.

However, in

a1~!

the

comparisons made, the fibrocystic disease grandpc.rents had the larger
families.

'fhese results >'lere presented with great reservations about

their biological significs.nce; end with the realization that the
magnitude of the heterozygote advantage apparently shown is very much
greater than "V'lould be needed to maintain the gene at a steady
in the

fre~uency

cu~~~nity.

If one uses the data describinG larger family size in i.letero-

7
zygotes an explanation of greater fertility is needed.

This could op-

era.te in two ,\fays, firstly, fertilization could be more ef£'icient;
secondly, embedding of
efficient.

OVcl!!l

and Tl1aintenance of pregnancy could be more

Secretions in the female genital tract and their relation-

ship to fertility is not completely kno'dn, but it. is thought that the
increa:s;e in sodium chloride in cervical mucu;:; pea}::s at the time of
ovulation.
8h01'18

The cervical

spinnbarkiet.

~ucus

at this time becomes less viscous and

This seems to favor sperm passage.

This raises

the possibility that the heterozygote may possess a. better Tucus-salt
relationship at ovulation for a lon>,:er time before and after ovula.~

+.;
~n
V.J;..U
•

Q 0
v,
/' i 10

'I'he difficulties raised by the high incidence of cystic fibrosis
"ii/auld be much less if homozygosity for several different autosomal
genes could cause cystic fibrosis.

Congential deafness for example,

may probably be caused by up to six different autosomal recessive genes
as well as being caused in several other ways, beth genetic and envir011rnental.

HOiiever, 1.n c;;rstic fibrosis the incidence in cousins with

affected children and also the low parental:::onsanguinity rate in
Caucasian populations indicates that only one gene locus is mainly
involved.

If the gene frequency is 1 in 50, the proportion of first

cousins affected should be about 1 in 200, which it has been found to
be.

There may well be, no\vever, rare variants of the disease due to

mutations similar to but not identical with that causing the common
form of' the disease.
If the affected sibs or patients, whose disease is mild and of
late onset also tend to 11.ave a form of the disease whicCl is mild and
of late onset, one might have to assume that another mutant gene other
than the usual gene is involved, perhaps another mutant at the same locus.

8
G~ten

two or three mutant genes may cause conditions which are very

similar clinically.
Dr. O. O. carterl~.xmmarizies the need for further research into
the gtmetics ai' cystic fibrosis as follo,{ls:

1.

Surveys, preferably

prospecti ve, of' the incidence in tlle many areas of the \vorld for 1,vhich
figures are not yet available. ( A screening test in the
be most valuable here.)

2.

nel~born

l'Tould

Determination oftthe relative parental

consanguinity rate in areas of low incidence of the disease.

5.

The

detection of heterozygotes which may have to wait, for the determination
of the basic biochemical anomaly.

4.

The determination of the selec-

tive advantage of heterozygotes in the areas of high incidence.

5.

The

prevention of the disease in the incidence areas will have to came by
tCle routine detection of the

4;~

of children ';°iho are heterozygotes and

,'!arning them against marrying each other.
No clinical anomalies have been definitely shown to occur unduly
orten in those known to be heterozygous for the mutant gene, for example parents of children ''''ith cystic f'ihrosis.

Olaims to demonstrate

a variety of pulmonary and gastro-intestinal disorders in heterozygotes
have not been conf'irmed.
~m'Jal!-':I1ent

Most studies show that such parents had no

in respiratory functions.

The small increase in sweat

sodium and chloride in adults with chronic respiratory disease, if it
exists at all, is no reason for suggesting that they are heterozygotes
for the gene of cystic fibrosis.

The problem is to find what the extra

fitness of heterozygotes for cystic fibrosis is due and any substantial
proneness to disease in heterozygotes is difficult to reconcile with
the incidence of the disease.
~vould

If such disease proneness exists, it

i,nply an even greater fitness in other respects.

It is conceivable

9

that a minor degree of up.i'i tness in

hetero~rgotes

in adult life might

be compensated by increased fitness in childhood, but this is improbable.
The general rule with autosomal recessive conditions, is that it
is not possible to pick up tho.3e heterozygous for the mutant gene until
t:Ie direct effect of the gene mutation, at least in terms of the enzymatic activity of the protein product of the gene, has been found.

This

is in contrast with the X-linked conmtions in which, because of the
inactivation of one of the X chromsomes, it is often possible to pick
up female heterozygous for mutant genes by relatively crude clinical
tests.l 4
The idea of being able to detect the heterozygous state is the key
to the success in the driYe to decrease the incidence of cystic fibrosis.
Even with the expert medical care given at various University centers
for cystic fibrosis the death rate remains high.

The survival time is

being lengthened gradua.lly and mild cases are living into adulthood, but
tne basic defect of the disease remains unknown as does the cure.

So,

at present, t:1e only hope for cure is to find the etiology of the disea.se and hopefully correct the defect.

But the surest and easiest

mett,od of controlling the disease, lies in the prevention of the disease.
This could be accomplished by being able to detect the carrier state
and thus "Iarn carriers of the consequences \qhich could result from
their mating with another oarrier.

Most of the new and exciting re-

search in cystic fibrosis is now being directed toward the goal of being
able to detect the heterozygote and thus prevent the diseas,,;_
The first area explored in the detection of the carrier state was
an evalution of the idea that the heterozygote might have an increased
sodi,)1l1 cl1loride in sweat as is noted in the patients with cystic fibrosis.
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Mvl tiple factors are known to affect the concentration of s8_1 t in

The rate of sweat secretion, skin

t~nperature,

salt intake,

adrenal function, acclimation to heart, snd the region of the body
from which the sweat is obtained, are all known to affect its chloride
concentration.

The choice of drug used to stimulate sweating and the

analytical

met~od

used in the assay can also affect the chloride value

obtained.

Thus it is difficult to compare different surveys reported

in the literature, making it imperative for each laboratory to determine its o-.,.m normal range of sweat chloride value by their

Oim

technique.

It is not surprising to find a binodal population of normal adults
since it is noW accepted that a percentage of known heterozygotes have
a moderate elevation of sweat chloride.
number of

u~~~own

There must be an even greater

heterozygotes in the 'normal' population than there

are known heterozygotes who have by chance mated "Ii th another heterozygote and given birth to a child with cystic fibrosis.

One can only

speculate regarding the possibility that nermal adults with slightly
elevated S'i'Tes.t chloride are heterozygous i'or cystic fibrosis, since
there is not as yet any truly diagnostic tests to perform in an asystematic indiVidual.

Long term observation of such individuals may be

rev,arding in the pulmonary problems which may develop in such individuals with increased frequency.
Most data from parents of cystic fibrosis patients indicate there
is an increase incidence of elevated chloride levels in the sweat of
these individuals.

The mean chloride value for this groups was signif-

icantly higher than normal controls.

The percentage of individuals with

s,veat chloride values over 40 meq/l. is signli'icantly higher for the
parents of cystic fibrosis children compared to th.e normals.

11
Normal siblings of cystic fibrosis patients did not show any great
deviation from normal children in this regard, but if the trend of the
normal data is correct, a greater number of these siblings ma.y develop
higl1er sweat chloride values as they reach adulthood, resulting in a
true rise of mean chloride values

~1i th

age in this group_

It was noted in one study concerning the sweat electrolytes in
carriers, that in most instances it is not possible to diagnose heterozygosity for cystic fibrosis, with any degree of certainty, on the
basis of a single S\'leat chloride concentration determination.

This is

attributed to the fact that the distribution of single values in normal
i2:1:ldivi~.m:ti

in known heterozygotes overlap by 70 to 805:b.

However,

the fact still remains that the distribution of the sweat chloride values
is higher in knOltffl heterozygotes does suggest that the recessive gene
is expressed to some extend.
One may

:~,ostu18te

that the heterozygctes nsve two popUlations of

sweat secreting units, normal and affected, each independently distribuy.ed on the skin, and each having its
distribution.

Olm

characteristic mean and

A total pooled bod:! sw"eat test ,\-lQuld yield a sweat chloride

value '(,hieh was a mean of both populations of the secreting units and
,fould be a function of the :nean of each population and the relative
freqvency of each, the latter being conditioned by ti'J.e expressivi ty
of the recessi va gene.

Those heterozygctes id th affected genes of low

expressivity might fall within the range of normal S'.'leet chloride values.
'rne value obtained by weighted patch collection is a sample mean
of a number of secreting units.
bution around the true mean.

And sample means have a ncnaal distri-

The chloride value of' sweat collected f'rom

a simple patch, then depends on:

1.

The l:lJ.eans of normal 8.nd ai'fected

12

The expressivity of' the affected gene.

secreting unit populations.

3.

The relative

f*re~u_ency o~

particular patch collection.

normal and affected units sampled by the
By performing multiple patch collections

on different 8i tes on 8_n individual, the mean and varianc e of the set
of sample means can be determined.
the mean of the sample

s~t

In a homozygous normal individual,

will be low and the variance small, since

the secreting unit are from only one population.

In the heterozygote,

the mean of the samples may be normal or elevated, depending on the two
popula.tions means and gene expressivi ty, but the variance will be large,
since the population is a double one.
So it was proposed that using

bot~l

the mean and variance of a set

of sweat tests on an individual, it might be possible to distinguish
between homozygous normal individuals and carriers of the disease.

The

problem of aSSigning an unknown individual, such as a sibling of' a child
~li th

cystic fibrosis to either normal or carrier population on the basis

15
of these t~To variables is one of' discriminating-" ana1vsis.
.
The results using the discriminate analysis technique sho1'led
of the parents and

8,1~

8ll7~

of the genetically expected number of siblings

were identificalDle as heterozygotes.

Thus, 16% of the parents and 17%

of the sibling who fall in the normal zone represent heterozygotes of
very low expressivity.

These may change zones to a diagnostically

significant extent on repeat testing.
It is conceivable that under appropriate stress, as applied in
determinmsthe carrier of phenylketonuria, the remaining parents and
sibling could be i'ound to differ in some respect from the control
group.

'the fact that some heterozygotes are detectable in cystic fibro-

sis lends weight to ti:1e theory that even a so-called recessive gene has

_ _ _ _ _ _ _ _ _._6_"'rJ'¥_"''''_ _

''''·~---~~-·

_ "_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

13
some expression in the heterozygous state.

One type of stressful sit-

uation tried in order to bring out the hidden heterozygote >vas a salt
deprivation test. 16
It is known that norma.l individuals depleted of salt will produce
sweat of low electrolyte concentration because of the salt conserving
influence of aldosterone.

Children with cystic fibrosis, however, under

the same conditions, continue to produce salt of high electrolyte concentration in spite of normal levels of' aldosterone.

It was thought

then, that perhaps the heterozygote carriers of the cystic fibrosis gene
when subjected to similar conditions of salt deprivation, might be unable
to conserve sa.! t in the same way as that shovln by the aff'ected children.
This conjecture became the basis of a study, to subject kno\Yn carriersl:
to a low sodium chloride diet in hopes it might unmask the recessive
disorder.
in

Svleat

But the results ,;'ere unproductive as there was a decrease
chloride values of similar magnitude in both parents of cystic

fibrosis patients and controls as the diet continu:ed.

It

"JaS

concluded

that the stu.dy of sweat electrolyte levels in salt deprived su.bjects
is of no value in the diagnOSis of cystic fibrosis heterozygotes.
It can be concluded from the studies of sweat chloride levels in
adul ts and children, that a Svleat chloride assay is an excellent and
simple procedure for confirming a diagnosis of cystic fibrosis in a
child or young adult.

A normal chloride level should strongly suggest

that the patient probably does not have cystic fibrosis and that another diagnosis should be made.

In adults, the test has only limited

usef'ulness for detecting heterozygotes or carriers of the cystic fibrosis
gene, although kno'tIn heterozygotes and adults with chronic lung disease
were found to have an increased incidence of individuals with slight to

moderate elevation of sweat chloride.

In addition most data suggests

that the normal adult population is a dual population in regard to the
level of' chloride in sweat, leaving room for much speculation regarding
the significance and meaning of' the higher chloride group.

Evidence

was obtained suggesting that the high chloride normal group appears
on~y

in adulthood, and that these individuals may have had lower sweat

chloride values during childhood.
The normal range of' chlorides values in adults has not conclusively
been deCided, but a.ny value above 40 meo/I. sho-dld probably be viewed
i'li th

suspicion.

This inexact upper limit of normal does not affect

the use of' the assay as a test of cystic fibrosis, in as much as the
cnare.cteristic sweat chloride in homozygous is in an extreme range that
does not appear to overlap the values found in the remaining population.
So at this time the main value of the sweat chloride assay is for the
. oI-, th".e 'nomozygous cys t'~c
'
d ~agnos~s

,17,18

.p"
J.~oros~s.

Another type of study was undertaken in hopes that the minor
labial salivary glands would reveal changes that would be used to distingl.lish not only patients with cystiC fibrOSis from nonnal patients,
bU.t also patients heterozygous i'or the gene for cystic fibrosis from
normal patients. 19

Af'ter intensive studies only one characteristic

of cystic fibrosis stood out, plugs of a smooth, eosinophilic material
ir. the lumen of some acini.

The presence of these eosinophilic plugs

was.the criterion used to designate that a minor labial submaXillary
or parotid salivary gland was abnonaal.
The criterion abnormality, acinar plug of eosinophilic material,
was confinned to be present in over 8070 of' children ,'lith cystic fibrosis.
The abnormality was rS.re in children undeY 20 years of age who did not
have cystic fibrosis.

The abnorm8.1i ty beC2<Ille rela;'"tively more f'requent

15
in both adult groups, parents of children with cystic fibrosis and
normal controls, as the age of the groups increased.

This type of

tasting of the labial minor salivary glands could be obtained with
a minimum of trauma, so that studies could be easily done on heal ti:-.y
persons to see if criterion could be found peculiar to the heterozygote
carrier of the gene for cystic fibrosis.

The impression that parents

of cnildren with cystic f'ibrosis show the cri te'rion abnormality in
tae mucous salivary glands at an earlier age than do normal adults
is strong, but cannot be proved from the presented data.

The results

may indicate an accelerated rate of change in carriers caused by a
basic glandular defect which normally occur slowly over many years o
(~

the other hand, the changes may be

entirely~~specific

and could

soley be due to morphcil.ogicexpressicn of the gland when subject to
stress or injury.

So in conclUSion, these changes appear earlier and

more frequently and significantly more severely in adults who are
known heterozygous for cystic fibrosis,

~~t

this criterion cannot be

used as the sole bases to identify the heterozygous.

These observations

mainly suggest that factors are operating in patients \'1i th cystic
fibrosis which affect certain tissues or their secretions in sll.ch a
\vay that ci1anges occur in childhood vlhich would ordinarily not be seen
until later in adult life.
Cme of the most promiSing studies in the i'ield of cystic fibrosis
.

~s

,
.
oe~ng

'd
.20
on 'oy Dr . AS
. ,pOCK.

carr~e

His group is studing the effect

of sera from patients with cystic fibrosis upon human and animal respiratory trect epithelium.

First observations indicated that these sera

produced an asymmetrical cilia.ry beat.

The study \'las designed to elu-

cidate the significance of' this abnorulal beat and to detect factors 1·11 thin the sera of

~atients

with cytic fibrosis responsible for the beat,

16
snd possibly help clarify the pathogenesis snd genetics of' cystic
:eibrosis.
It has been snO,'l1n that ciliary ;11Otili ty is essential f'or maintemince of' proper respiratory function by constantly moving the mucus
blanket of the respiratory tract upward to\-Iard the oral cavity.

AI-

though it has not been ?roven that ciliary motility is impa.ired in
patients with cystic

fibrosi~,

these individuals do show damage to

cilia and changes in the volume and consistency of the mucus which reduce effective transport and result in bronchial obstruction with pulmona.ry dysfunction.
The nature of the study \-ras in vitro, the serum from a patient
with cystic fibrosis was ap"Dlied to a tissue specimen, rabbit tracheal
epi thelium.

An asymmetrical beat ,,/as observed wi thin fi va to ten min-

utes and perSisted ror a period up to one hour.

Ai'ter this time the

border became obscured \)'i th desquamated cells:_and vIas no longer suitable
for study.

The degree of altered activity was unrelated to the age of

the patient, severity of the disease, or sweat chloride level.
contrast, sera from all of the control patients produced no

In

~tl terations

in the ciliary beat in a similar time period.
By. bioassay"techhique the fraction in the sera of these patients

"thich was reponsible ror the asymmetrical beat ''las identif'ied.

The

major component was found to reside in the euglobulin, lvater-insoluble
fraction.

To determine whether the abnorma_l serum rae tor was also pre-

sent in heterozygotes, sera from some of the parents of the patients
used in the study were tested.

The sera from 28% of the parents 'Ylas

capable of alternating the ciliary rhythm.

In further testing, the

remainer o:f' the parents \'/hose '1hole sera failed to produce an asymmettrical best, euglobulin (lvster in-solulbe) fraction was prepared and
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examined.

\1i th a concentrated euglobulin fraction produced, en asymmet-

rical beat 1::1 all these parents

vlaS

noted.

1:!hereas, the ell.globulin frac-

tion prepared in a similar mannt9r from the sera of an equal number of
ad"ult volunteers with no family history of cystic fibrosis was positive
in only one case.

This one subject had a normal sweat chloride test.

The presence of this unique protein in the serum is significant
in vie",! of the identification of mucoprotein in bog,y fluids of cystic
fibrosis patients by other investigators.

Dische, initially observed

the presence of' abnormal mucoprotein in duodenal fluid.

!'1ucoprotein

complexes have subsequently been described in sweat, submaxillary saliva,
in urine and most recently in the feces.

At uresent no direct corre-

lation has been made between the protein fraction which has been found
in the sera and the mucoprotein noted by these other \>1orkers in body
secr.eticns of patients with cystic fibnosis.
The findings of a

seru~

factor as well as the abnormal protein

found in the urine, suggests that the suspected

enzJ~atic

cystic fibrosis may not be limited to the exocrine glands.

defect in
The abil-

ity of cystic fibrosis sera to cause an asymmetrical beat in cilia of
respiratory tract epithelium obtained from s_nimals and humans initially
led to postulation that the

asy~etrical

beat could be responsible for

the retention of mucus by cystic fibrosis patients.
of ciliary function could

potentiat~

tions seen in this disease.

This abnormality

ti16 effect of the viscid secre-

It should be emphasized that the in vitro

effect renorted above has not been seen in vivo.

Examination of nasal

polyps from patients with cystic fibrosis immediately upon removal show
normal ciliary motility.
Dr. Spock1s group is currently

desi~ing

experiments to improve

purification and identification of the serum protein by various inununo-

18
chemical techniques.

It is hoped that this will enable them to determine

the nature of' the protein and its constituents.

This information 'tlill

provide a more rapid and simnler assav technioue and perhans a 'Oossible
-

~

" " . . I .

-

.!.

...

...

clue to the pathogenesis of cystic fibrosis.
Another attempt to detect heterozygotes is being carried on by
Danes and co-workers. 2l

Initially this work has looked ve~J promising.

Skin fibroblast cultures were used as the means of' detecting the cystic
fibrosis patient and the heterozygous ca1'rier,a8 they showed easily recognizable cytoplasmic intravesicular metachromasia.

The existence of

a cellular abnO!'lilali ty recognizable in the fibroblasts of' these individual offers an experimental oPF'Ortuni ty to study tb.e primary defect of
this common inherited disease at the molecular level.
In this study, skin biopsies were obtained from the cystic fibro-

-

sis patients, their parents, t1eal thy control s and persons ilit.::l miscellaneous illnesses.

The cystic fibrosis patients all were diagnosed

poei tive by abnormal l:\\;ieat tests.

Monolayer skin fibroblast cultures

were established by tissue culture procedures whicn were then stained
and examined.

Final resu.l ts snol-led subeulrt:.ures from heal thy unrelated

individuals and patients v1i th a variety of other disease contained an
occasionEtl cell sl:10wing metachrcmatic

i~\clusions.

\'fbile cultures de-

rived from the patients with cystic fibrosis contained large numbers
of fibroblast showing evident cytoplasmic metachromasia.

The metachro-

ma1iic material appeared to be contained w'i thin vacuoles or vesicles and
"18S

not distributed evenly throughout the cytoplasma.

The size and

shape of the inclusions "Jere not uniform and they were often restricted
to one cytoplasmic area wi thin the cell.

The proportion of cell s con-

taining metachromatic inclusions i:..1creased for apprOXimately two months
after the establisllment of the monolayers snd then remained constant.
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Although the proportion of metachromatic cells did not vary signicantly
after the fifth subculture, the number or vesicles per cell continued
to increase.
Fibroblast cultures derived from clinically unaffected carrier
parents contained cells with metachromatic material similar to that
seen in skin fibroblast obtained from their affected children.

The

time sequence for the appearance of metachromasia was similar to that
seen in cultures from the affected individuals.

Although there was

some variation in the percent of metachromatic cells in the heterozyr;ous
carriers, as well as the number of inclusions per cell, multiple biopsy
specimens from the same area from a single individual sno\'led only slight
variation.

Cytopathic effects including vacuole formation and cyto-

plasmic granulation have been noted in human cell cultures as a result
of mycoplasma infection.

A considerable effort was made to determine

i'ihether there was any relationship bet"leen the appearance of cytoplasmic vesicles and the infection of cultures with mycoplasma.

No corre-

lation betv.reen the presence of mycoplasma and cytoplasmic vesicles was
evident.

Since mycoplasma infection was randomly present in the cul-

tures here, the possibility that it was responsible for the cytoplasmic vesicles in the positive cases is highly unlikely.
Several genetic disorders can be investigated in cultured £'ibroblasts.

The 8.ddi tion of cystic :f'i ')rosis to this list is noteworthy,

since both clinice-l and chemical stu:dies have suggested that cystic
!~ibrosis

is an exocrine abnormality rather than a multicellul&r dis-

order involving connective tissues.

The detection of a recognizable

cell marker in both the affected 8nd carrier states provides

an in

vitro model for investigation of the primary molecular abnormality in
this disease.
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The metachromatic appearance of' the cultured cells derived :Crom
pa tients "Ii th cystic fibrosis dif:Cers from that observed in the mucopolysaccaridoses in which the metachromatic granules are more evenly
distributed

thro'~:ghout

the cytoplasm.

The striking variation in the

degree of cellular metachromasia in cultures derived :Crcm both aff'ected
indi vidual s and known carriers is similar to that seen in cell cultures
established from the autosomal recessive mucopolysaccharidoses.

As in

the mucopolysaccharidoses, there seems to be correlation between the
severi ty of t:'1e clinical disease, the number of metstchromatic cells or
the number of inclusions per cell in the cultured skin fibroblast.
Despite intensive clinical and laboratory investigations extending
over many years, the primary inherited de:Cect in cystic fibrosis remains
unknown.

The glycoprotein-rich secretions

e essi ve t;t,mounts in

cystic_~

w~~ch

are produced in ex-

fi br.osis do !;lot seem to di:Cfer 'luaIi tati vely

f'rom those i'ound in healthy individuals.

Findings indicate that skin

fibroblasts, derived from affected individuals and carriers grown in
cell cultures, contain characteristic metachromatic inclusions which
may reflect the primary inherited defect in this disease.

The

c~em

ical nature of' the metachromasia material has not yet been elucidated.
It is noteworthy that carbohydrate containing proteins have not been
:Cound to give strong metachromasia.

An increase in sulfate groups

attE'-Ched to the carbohydrate containing protein, may be responsible :Cor
the staining reaction.
In this series all the known carries shol'red cel1ular metachroma.sia,
and the results with unknown carriers were compatible with
carrier frequency of approximately 2 to 8 per cent.

th~

estimated

So, the approach

tl.ere seems to provide a simple method to identify heal thy carriers, and
affords a tool for

det~rmini~directly

the carrier frequency of this
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highly lethal gene in the healthy population.

Additional family

studies will be required before the reliability of cell marker for
detecting carriers can be established.

The possibility that the appli-

cation of this technique will reveal genetic heterogeneity in cystic
fibrosis can also be entertained.

The recognition of a cellular ab-

normality in cultured fibroblast permits a more direct investigation
of the molecular basis for this inherited disease,•.
The latest effort to detect the cystic fibrosis heterozygote
has been reported by J.VI. Balfe and associates. 22

Their motivation

for this study stemmed from the work of Mangos and

l~CSherry

in ,..hlch

they de-monstrated that the sweat from patients with cystic fibrosis
inhibits sodium transport in the duct system of the rat parotid gland.
This latest study examines the compotents of active transport in another cell membrane system, the erythrocytes of patients with cystic
fibrosis and their parents.
Balfe's study shows that the mean concentration of sodium per liter
of red blood

cel~

for affected and the control group was very similar.

The sodium efflux studies were then done with erythrocytes from patients with cystic fibrosis and parents of patients each of these
studies were coupled with a control.
THO

sodium pumps were described:

1.

Pump I is that component

of sodium efflux which is inhibited by the addition of ouabain to a
medium which contains sodium and potassium.

2.

Pllll1P II is another

decrement in the efflux of sodium which is due to the addition of
ethacrynic acid to a medium which contains maximally inhibi te.ble concentrations of ouabain.

The remnant of' the efflux, that is, the

CCID-

panet of the total ef'flux unaccounted for b;! pumps I and II is referred to as the "leak".

This presumably correlates with the permeability
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of the red blood cell membrane.
After data. for normals was compiled, patients with cystic f'ibrosis were studied under identical circumstances.

Results showed the

mean decrease in pump I is 15% of' control values.

Pump II differences

were even more strikingly decreased in patients with cystic fibrosis
as

pu~II

was only

53%

as active as their controls.

i'lere statistically significant.

These differences

The "leak" parameter

\WS

statistically

significantly less in the patients as well.
So, patients with cystic fibrosis have a normal concentration of
sodhun in red blood cells, but a diminished active efflux of sodium.

This suggests that the passive influx of sodium, the "leak l ! parameter,
might possibly be diminished, and the "1eak ll parameter of sodium efflux
measured

lid

th isotopes is diminished.

In erythrocytes from parents of these patients, there waS no
difference in pump I nor in the associated ouabain sensitive ATP activity, but there was a

56%

dimi~J.tion

in pump II.

The magnitude of

the depression in the acitivitv of pUlllP II is similar to that seen in
~

,.

the patients

~'1i th

.1,

..

cystic fibrosis.

The final conclusion of this investigation demonstrates a dimini shed active transport of' sodium in the erythrocytes of patients
\>[i

th cystic fibrosis.

Of special significance is the marked decrease

in that 'I'lhich is defined as pump II in the parents.

This o.iJantitative

marker of the heterozygous carrier of' the disease rna:' be useful in
genetic

st~ldies

and in genetic counseling.

In

s-(~mmary

the follo\-;ing may be concluded about the carrier of

cystic fibrosis and its detection.

No consistent clinical abnormalities

have been found in these individuals.
"\'\[i

Studies of parents of patients

th cystic fibrosis have shovlll no increased prevalence of respiratory
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and gastrointestinal disease.

The mean sw·eat sodium concentration

and the sodium content of nails are frequently increased in km:n'f"n os.rriers, unfortunately, the heterozygous values overlap thosefound in
normal individuals, and so these tests are unsuitable for the detection of carriers.

The most promising studies in the area of cystic

fibrosis detection are: (1)

'l'ne bioassay technique reported by Spock

and cO-1rlorkers in 1967, 20 this test is based on the observe.tion that
sere. of carriers cause a dyskinesis of ciliary motility of rabbit
tracheal cells in vitro.

(2)

The detection of metachromasia in fi-

broblast of carriers of cystic fibrosis by Dr. Danes and associates. 2i

0)

The detection of a red blood cell transport defect of patients

with cystic fibrosis and in trleir parents.

This investige.tion of J.W.

Bul:te and co~orkers,2~ives a quantitative marker of the heterozygous
carriers of cystic fibrosis.
Vii th ftl.rther research and modifications of present data it seems
reasonable that soon there will be a practical and simple means to detect tIle 2-8% of the population thet are carriers for the cystic fibrosis gene.

This type of testing would be of special value to high risk

groups, such as sibs of affected patients and related married couples,
as well as in the general population.

If the information of being a

carrier were made available to newly married couples good genetic
counseling eQuId be provided.

The risks involved of' having affected

children could be explained.to these couples.

Then each of the carrier

couples could decide for themselves with the aid of genetic counseling
if they Nould want to have children or not.

So, theoretically this

:night be the solution to end cystic :t'ibrosis simply with its prevention.

Of course, the incidence would never be reduced to a zero level but with
the kno\vledge of known carriers it seems likely the incidence rate can
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be reduced to a lower level than the present estimated incidence of
1 in 2,500 live births.

With the continued ingenious research in

cystic fibrosis and the ever present effort in the area of carrier
detection, there remains hope that the molecular basis ox" the disease
will be discovered.

And with this information available a correction

of the defect might be possible. 2"

24,

15

BIBLIOGRAPHY

1.

N. Sinarhava, Ann. Gene., "Genetic Study of Mecoviscidosisll,
Volume 7, 84-7, Jan., 1964

2.

O. O. Carter, Hosp. !<Ied., 1l0linical Genetic II , Volume 41, 351-353,
March, 1967

3.

G. O. \flooten, Lancet, liThe Prevalence of Respiratory Disease in
Reterozygotes Tor the Gene for Cystic Fibrosis of the Pancreas II ,
Volume 22, 1348-50, June 26, 196;

4.

G. Lieberman, luner. Jour. Med. SCi., "Evalue.tion of SYleat Chloride
Assay in Adults-Use of Filo-Carpine Iontophoresis", Volume 21+6,
537-49, June 196;

5. s.w.

Wright, Amer. J. Hum. Genet., IlGenetic Studies on Cystic Fibrosis in H~n'l/aii ", 157-8, March 1968

6.

D. M. Dank, Ann. Hum. Gene., "A:Genetic Study of !"ibrocystic Disease
of the Pancreas", Volume 28, 323-56, Iitiay 1965

7.

A.D. Merritt, Jour. Lab. Olin. r";:ed., IIIncidence and fvlode of Inheri tance of Cystic Fibrosis ll , Volume 60, 998-999, April 1962

8.

A. J. Knudson, Amer. J. Hum. Genetic, "On the Selective Advantage
of Cystic Fibrosis Heterozygotes", Volume 19, 388-92, May 1967 -,

9.

C. M. Anderson, Bibl. Pediatrics, lIComments on Possible Existence.,
and Nature of a Hete!"ozygote Advantage in Cystic Fibrosis ll , Volume
86, 381-7, Aug., 1967

10.

G. Peter, Lancet, "Chromosomes in Cystic Fibrosis", 978-9, May 4,
1968

11.

B. Smoller, luna. J. Dis. Child., IIStudies of' Genetic Mechanism of
Cystic Fibrosis of the Pancreas!!, YoLlnO 98, 277-292, Sept., 1965

12.

P. Honey:na~n, Arner. J. RUIn. Gene., nCystic Fibrosis of the Panreas-A."l Estimate of' the Incidence", Volume 17, LJ61-5, k.lg., 1965

13.

C.

14.

1,]

15.

16.

o. Carter, Bib1. Pediatrics, IiGenetic Aspects of' Cystic Fibrosis
of' the Pancreas ll , Volume 86, 372-80, July, 1967

".

y'. Hallett, Amer. Revie\,l Resp. Disease, "Absence o!~ Detrimen.tal
Effect of' the Carrier State for Oystic Fibrosis Gene 11 , Volume 92,
714-24, Nev., 1965

,,~. Sproul, Journal of~ Pediatrics, HDiag110sis of Heterozygosity for
Cystic Fibrosis by Discremenatory Analysis of Sweat Chloride
Distribution li , Vohxme 69, "159-770, Nov. 1966

YI. F. Meyers, Oanad. }.fed.

...

tJ • ,

IlS1rleat Ohlorides in Salt Deprived

Cystic Fibrosis Heterozygotes ll • Volume 92, 926-929, April 1965

17.

\1. A. Marsh, Pedi2trics, "Critical .study of the Sweat Testfor
the Detection of' Heterozygotes of Cystic Fibrosis fl , Volume 92,

1495-6, rl'ov. 1962

18.

A. Heuselen, Path. BioI., I1Gene Carriers of' Mucoviscidosis and
the Determination of' Sodiul.l:l Chloride-Preliminary Results ", Volume
13, 274-8, March 1965

19.

L. R. S,yeney, Pediatrics, liThe Invol"vement of' the L2.bia1 Mucous
Salivary Gland in Patients Nith Cystic Fibrosis and the Het,erozygote
State ll , Volume 40, 421-4, Sept. 1967

20.

A. Spock, Bibl. Pediatrics, II In Vitro Study of Oiliary Motility
to Detect Individuals ..lith Active Cystic Fibrosis and Carriers
of the Disease ll , Volume 86, 200-6, Feb. 1967

21.

B. S. Danes, Lancet, Ii A Genetic Cell ll~arker in Cystic Fibrosis
of the Fancreas ll , Volume 75)1, 1061-6;, May 18, 1968

2c;.

J. 1:1. BLl.lfe, C. Cole, L. G. 'V'fe1t., Science, "Red Oe11 Transport
Defect in Patient with Cystic Fibrosis ancI in Tlleir Parents",
Vobme 162, 689-90, Nov. 8, 1968

23.

A. G. Hot'J.1sky, Amer •.~f. obstet.-G'.Tnec., l!Genetic PrognosiS and
CO'lnseling tl , Volume 90, 122-1-41, D~c. ° 1964

24.

R. R. Tips, Amer. J. Disease Chilq., uThe 1;1ho1e Family Concept in
Clinical Genetics ll , Voiume 107, 67-76, Jan. 1964

2:5.

R. R. '!:ips, Texas J. E,1ed., "Genetic Counse1ing ll , Volume 60,650-3,
Aug. 1964

